Locus Cell Co., Ltd. (TPEX:6891)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.00
-8.00 (-11.76%)
May 5, 2026, 9:20 AM CST
Market Cap13.60B +242.6%
Revenue (ttm)12.74M +440.7%
Net Income-181.54M
EPS-0.91
Shares Out200.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,759,421
Average Volume3,273,837
Open67.00
Previous Close68.00
Day's Range59.80 - 69.30
52-Week Range20.70 - 94.70
Beta2.69
RSI62.34
Earnings DateApr 30, 2026

About Locus Cell

Locus Cell Co., Ltd. focuses on contract development and manufacturing organization (CDMO) services for cell therapy related products in Taiwan and the United States. The company is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Yu-Hsiang Chang
Employees 53
Stock Exchange Taipei Exchange
Ticker Symbol 6891
Full Company Profile

Financial Performance

In 2025, Locus Cell's revenue was 12.74 million, an increase of 440.66% compared to the previous year's 2.36 million. Losses were -181.54 million, 60.6% more than in 2024.

Financial Statements